Optimization and in vivo evaluation of quetiapine-loaded transdermal drug delivery system for the treatment of schizophrenia

References

• Tiihonen J, Mittendorfer-Rutz E, Majak M, et al. Real-world effectiveness of antipsychotic treatments in a Nationwide cohort of 29,823 patients with schizophrenia. JAMA Psychiatry. 2017;74(7):686–693.
   PubMed Web of Science ®Google Scholar
• Schizophrenia Factsheets details. Geneva: World Health Organization; [updated Apr 2018; cited 2019 Jul 06]. Available from: https://www.who.int/news-room/fact-sheets/detail/schizophrenia.
   Google Scholar
• Clemency BM, Eggleston W, Lindstrom HA. Pharmacokinetics and pharmacodynamics of naloxone. Acad Emerg Med. 2019;26(10):1203–1276.
   PubMed Web of Science ®Google Scholar
• Potu AR, Pujari N, Burra S, et al. Formulation and evaluation of buccoadhesive quetiapine fumarate tablets. Braz. J. Pharm. Sci. 2012;48(2):335–345.
   Google Scholar
• Highlights of prescribing information. U.S. Food and Drug Administration [updated Nov 2009. cited 2019 Jul 6]. Available from: https://www.accessdata.fda.gov. < drugsatfda_docs > label
   Google Scholar
• Imam S, Ahad A, Aqil M, et al. Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: in-vitro characterization, and in-vivo appraisal. Mater Sci Eng C. 2017;75:1198–1205.
   PubMed Web of Science ®Google Scholar
• Imam S, Aqil M, Akhtar M, et al. Formulation by design based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study. Drug Deliv. 2015;22(8):1059–1070.
   PubMed Web of Science ®Google Scholar
• Diez I, Colom H, Moreno J, et al. A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. J Pharm Sci. 1991;80(10):931–934.
   PubMed Web of Science ®Google Scholar
• Mittal A, Sara US, Ali A, et al. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine. Pharm Dev Technol. 2009;14(4):422–434.
   PubMed Web of Science ®Google Scholar
• Adena SKR, Upadhyay M, Vardhan H, et al. Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design. Drug Dev Ind Pharm. 2018;44(3):493–501.
   PubMed Web of Science ®Google Scholar
• Politis SN, Rekkas DM. Development of a fast, lean and agile direct pelletization process using experimental design techniques. Drug Dev Ind Pharm. 2017;43(4):545–557.
   PubMed Web of Science ®Google Scholar
• Xu X, Khan MA, Burgess DJ. A quality by design (QbD) case study on liposomes containing hydrophilic API: II. Screening of critical variables, and establishment of design space at laboratory scale. Int J Pharm. 2012;423(2):543–553.
   PubMed Web of Science ®Google Scholar
• Sarkar G, Saha NR, Roy I, et al. Taro corms mucilage/HPMC based transdermal patch: an efficient device for delivery of diltiazem hydrochloride. Int J Biol Macromol. 2014;66:158–165.
   PubMed Web of Science ®Google Scholar
• Kumar T, Gope S, Mondal D, et al. Assessment of morphology and property of graphene oxide-hydroxypropylmethylcellulose nanocomposite films. Int J Biol Macromol. 2014;66:338–345.
   PubMed Web of Science ®Google Scholar
• Bagyalakshmi J, Vamsikrishna RP, Manavalan R, et al. Formulation development and in vitro and in vivo evaluation of membrane-moderated transdermal systems of ampicillin sodium in ethanol: pH 4.7 buffer solvent system. AAPS PharmSciTech. 2007;8(1):5–7.
   PubMed Web of Science ®Google Scholar
• Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002;91(9):2076–2089.
   PubMed Web of Science ®Google Scholar
• Obaidat R, Al-Shar N, Tashtoush B, et al. Enhancement of levodopa stability when complexed with b-cyclodextrin in transdermal patches. Pharm. Dev. Technol. 2016;7450:1–12.
   Google Scholar
• Limpongsa E, Umprayn K. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system. AAPS PharmSciTech. 2008;9(2):464–470.
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Patil SA, Agnihotri SA, et al. Evaluation and controlled release characteristics of modified xanthan films for transdermal delivery of atenolol. Drug Dev Ind Pharm. 2007;33(1):79–90.
   PubMed Web of Science ®Google Scholar
• Yang Z, Teng Y, Wang H, et al. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: Formulation design and biopharmaceutical evaluation. Int J Pharm. 2013;447(1-2):231–240.
   PubMedGoogle Scholar
• Barot BS, Parejiya PB, Patel HK, et al. Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design. AAPS PharmSciTech. 2012;13(1):184–192.
   PubMed Web of Science ®Google Scholar
• Gupta V, Singh S, Srivarstava M, et al. Effect of polydimethylsiloxane and ethylcellulose on in vitro permeation of centchroman from its transdermal patches. Drug Deliv. 2016;23(1):113–122.
   PubMed Web of Science ®Google Scholar
• Rajan R, D SRN, Kajal G, et al. Design and in vitro evaluation of chlorpheniramine maleate from different eudragit based matrix patches: effect of platicizer and chemical enhancers. Ars Pharm. 2010;50:177–194.
   Google Scholar
• Aqil M, Sultana Y, Ali A, et al. Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization. Drug Deliv J Deliv Target Ther Agents. 2004;11(1):27–31.
   Google Scholar
• Mandrioli R, Fanali S, Ferranti A, et al. HPLC analysis of the no v el antipsychotic drug quetiapine in human plasma. J Pharm Biomed Anal. 2002;30(4):969–977.
   PubMed Web of Science ®Google Scholar
• Agency EM. European Medicines Agency (EMEA). Wiley Encycl Clin Trials. 2008;2736:1–20.
   Google Scholar
• Banerjee S, Chattopadhyay P, Ghosh A, et al. Accelerated stability testing of a transdermal patch composed of eserine and pralidoxime chloride for prophylaxis against (±)-anatoxin a poisoning. J Food Drug Anal. 2014;22(2):264–270.
   Web of Science ®Google Scholar
• David SRN, Rajabalaya R, Zhia ES. Development and in vitro evaluation of self-adhesive matrix-type transdermal delivery system of ondansetron hydrochloride. Trop J Pharm Res. 2015;14(2):211–218.
   Web of Science ®Google Scholar
• Prajapati ST, Patel CG, Patel CN. Formulation and evaluation of transdermal patch of repaglinide. ISRN Pharm. 2011;2011:651909–651909.
   PubMedGoogle Scholar
• Verma PRP, Banu V. Sustained release of theophylline from eudragit RLPO and RSPO tablets. Drug Dev Ind Pharm. 1996;22(12):1243–1247.
   Web of Science ®Google Scholar
• Rajabalaya R. Studies on effect of plasticizer on invitro release and exvivo permeation from Eudragit E100 based chlorpheniramine maleate matrix type transdermal delivery system. J Excipients Food Chem. 2010;1(2):1–12.
   Google Scholar
• Gungor S, Erdal MS, Ozsoy Y. Plasticizers in Transdermal Drug Delivery Systems. In: Luqman M, editor. Recent Advances in Plasticizers. Croatia: Intechopen; 2012. p. 91–112.
   Google Scholar
• Rahman M, Brazel CS. The plasticizer market: an assessment of traditional plasticizers and research trends to meet new challenges. Prog Polym Sci. 2004;29(12):1223–1248.
   Web of Science ®Google Scholar
• Kashinatha P, Shivakumar S, Singh P. Design and evaluation of transdermal film of valsartan by using modified polymer. J Pharm Res. 2012;5(5):2823–2829.
   Google Scholar
• Pharmacopeia US. Topical and transdermal drug products – product quality tests. United States Pharmacop. 2013;35:3–6.
   Google Scholar
• Pongjanyakul T, Kanjanabat S. Influence of pH modifiers and HPMC viscosity grades on nicotine-magnesium aluminum silicate complex-loaded buccal matrix tablets. AAPS PharmSciTech. 2012;13(2):674–685.
   PubMed Web of Science ®Google Scholar
• Mutalik S, Parekh HS, Davies NM, et al. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride. Drug Deliv. 2009;16(2):82–91.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human. Guidance for industry starting dose in initial clinical trials guidance for industry estimating the maximum safe. Pharmacol Toxicol. 2005;(July):1–27.
   Google Scholar
• Rhee Y, Huh J, Park C, et al. Conh∼-∼/n∼. Arch Pharm Res. 2007;30(9):1155–1161.
   PubMedGoogle Scholar
• Parhi R, Suresh P. Formulation optimization and characterization of transdermal film of simvastatin by response surface methodology. Mater Sci Eng C Mater Biol Appl. 2016;58:331–341.
   PubMed Web of Science ®Google Scholar
• Liu C, Fang L. Drug in adhesive patch of zolmitriptan: formulation and in vitro /in vivo correlation. AAPS PharmSciTech. 2015;16(6):1245–1253.
   PubMed Web of Science ®Google Scholar
• Williams AC, Edwards HGM, Lawson EE, et al. Molecular interactions between the penetration enhancer 1,8-cineole and human skin. J Raman Spectrosc. 2006;37(1-3):361–366.
   Web of Science ®Google Scholar
• Zhao K, Singh J. Mechanism(s) of in vitro percutaneous absorption enhancement of tamoxifen by enhancers. J Pharm Sci. 2000;89(6):771–780.
   PubMed Web of Science ®Google Scholar
• El-Kattan AF, Asbill CS, Michniak BB. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm. 2000;198(2):179–189.
   PubMed Web of Science ®Google Scholar
• Moreira TS, de Sousa VP, Pierre MBR. A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation. AAPS PharmSciTech. 2010;11(2):719–719.
   Web of Science ®Google Scholar
• Parhi R, Panchamukhi T. RSM-based design and optimization of transdermal film of ondansetron HCl. J Pharm Innov. 2020;15(1):94–109.
   Web of Science ®Google Scholar
• Ubaidulla U, Reddy MVS, Ruckmani K, et al. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech. 2007;8(1):E13–20.
   PubMed Web of Science ®Google Scholar
• Matlhola K, Katata-Seru L, Tshweu L, et al. Optimization of eudragit RS PO-tenofovir nanocarriers using Box-Behnken experimental design. J Nanomater. 2015;2015:1–11.
   Web of Science ®Google Scholar
• Moustafine RI, Zaharov IM, Kemenova VA. Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes . Eur J Pharm Biopharm. 2006;63(1):26–36.
   PubMed Web of Science ®Google Scholar
• Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004;272(1-2):1–10.
   PubMed Web of Science ®Google Scholar
• Liu N, Song W, Song T, et al. Design and evaluation of a novel felbinac transdermal patch: combining ion-pair and chemical enhancer strategy. AAPS PharmSciTech. 2016;17(2):262–271.
   PubMed Web of Science ®Google Scholar
• Arunan E, Desiraju GR, Klein RA, et al. Defining the hydrogen bond: an account (IUPAC Technical Report). Pure Appl Chem. 2011;83(8):1619–1636.
   Web of Science ®Google Scholar
• Philip B, Singh H, Pathak K. Preparation, characterization and pharmacodynamic evaluation of fused dispersions of Simvastatin using PEO-PPO block copolymer. Iran J Pharm Res. 2012;11(2):433–445.
   PubMed Web of Science ®Google Scholar
• Ren C, Fang L, Ling L, et al. Design and in vivo evaluation of an indapamide transdermal patch. Int J Pharm. 2009;370(1-2):129–135.
   PubMedGoogle Scholar
• Ahmad AM. Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines. Biopharm Drug Dispos. 2007;28(3):135–143.
   PubMed Web of Science ®Google Scholar